Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Soo, See Anna | Zailan, Fatin Zahraa | Tan, Jayne Yia | Sandhu, Gurveen Kaura | Wong, Benjamin Yi Xina | Wang, Brian Zhiyanga | Ng, Adeline Su Lyna | Chiew, Hui Jina | Ng, Kok Pina; b; c | Kandiah, Nagaendrana; b; c; *
Affiliations: [a] Department of Neurology, National Neuroscience Institute, Singapore | [b] Duke NUS Medical School, Singapore | [c] Lee Kong Chian School of Medicine-NTU, Singapore
Correspondence: [*] Correspondence to: A/Prof Nagaendran Kandiah, Director of Dementia Research Centre, Lee Kong Chian School of Medicine, 11 Mandalay Road, 308232, Singapore. Tel.: +65 6592 2653; E-mail: [email protected].
Abstract: Background:Young-onset cognitive disorders (YOCD) often manifests with complex and atypical presentations due to underlying heterogenous pathologies. Therefore, a biomarker-based evaluation will allow for timely diagnosis and definitive management. Objective:Here, we evaluated the safety and usefulness of cerebrospinal fluid (CSF) sampling through lumbar puncture (LP) in YOCD patients in a tertiary clinical setting. Methods:Patients with mild cognitive impairment (MCI) and mild dementia with age of onset between 45-64 years were evaluated. Patients underwent magnetic resonance imaging and their medial temporal lobe atrophy (MTA) was rated. LP side-effects and the impact of the CSF findings on diagnosis and management were analyzed. Results:142 patients (53 (37.32%) MCI, 51 (35.92%) dementia of the Alzheimer’s disease [DAT] type, and 38 (26.76%) non-AD type dementia) who underwent LP between 2015 to 2021 were analyzed. Using post-LP results and MTA ratings, 74 (52.11%) patients met the AT(N) criteria for AD. 56 (39.44%) patients (28 out of 53 (50.0%) MCI, 12 out of 51 (21.43%) DAT, and 16 out of 38 (28.57%) non-AD dementia) had a change in diagnosis following LP. 13 (9.15%) patients developed side-effects post-LP (11 (84.62%) patients had headache, 1 (7.69%) patient had backache, and 1 (7.69%) patient had headache and backache). 32 (22.54%) patients had a change in management post-LP, 24 (75.0%) had medication changes, 10 (31.30%) had referrals to other specialists, and 3 (9.40%) was referred for clinical trial with disease modifying interventions. Conclusion:LP is well-tolerated in YOCD and can bring about relevant clinical decisions with regards to the diagnosis and management of this complex clinical condition.
Keywords: Alzheimer’s disease, biomarkers, cerebrospinal fluid, dementia, lumbar puncture, mild cognitive impairment, post-LP complications, young-onset cognitive disorders
DOI: 10.3233/JAD-215453
Journal: Journal of Alzheimer's Disease, vol. 87, no. 1, pp. 479-488, 2022
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]